Search Results 2141-2150 of 17081 for glomerulonephritis.
The goal of this study is to determine the role of postprandial glucagon suppression and insulin secretion in the progression of glucose intolerance in people ...
Mayo Clinic's high-tech pursuit of precision alcohol addiction treatment featured image · Steroid dosage risks and benefits when managing lupus nephritis ...
Mayo Clinic researchers used a new approach to chemotherapy to more than double the typical survival rate for patients with stomach cancer and peritoneal ...
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...
Latest stories · Delivering innovative stem cell therapy to slow vision loss featured image · Mayo Clinic Q&A podcast: Addressing disparities to prevent disease ...
Julie Ferris-Tillman, Ph.D. January 21, 2026. New CT imaging oral contrast agent improves visualization of bowel anatomy, clinical trial ...
Safety and Efficacy of Simtuzumab (GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH) · Overview.
Clinicians at Mayo Clinic can use artificial intelligence (AI) tools to effectively screen patients for a weak heart pump via a simple electrocardiogram ...
Research · New oral anticoagulant drugs associated with lower kidney risks, Mayo Clinic research shows featured image · Science Saturday: Where future cures come ...
Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.